Clinical Trial Update: Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating the cumulative irritation potential of topical ZuraPrep formulations with and without IPA for prevention of surgical site infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• ZuraPrep
• ZuraPrep Without IPA

Snippet

Sponsor: Zurex Pharma, Inc. | Conditions: Surgical Site Infection | Phase 1 | Status: COMPLETED